Search research articles
Contact Us
Filters
Showing results (71-80 of 83) with videos related to
Page
of 9
Sort By:
Journal of Autoimmunity
|
June 3, 2015
Allelic and copy-number variations of FcγRs affect granulocyte function and susceptibility for autoimmune blistering diseases
Andreas Recke, Gestur Vidarsson, Ralf J Ludwig, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology
|
August 6, 2025
Lanadelumab's impact on hereditary angioedema control and quality of life across disease activity subgroups: Real-world evidence
Andrea Zanichelli, Walter A Wuillemin, Emel Aygören-Pürsün, et al.
Journal of Autoimmunity
|
August 20, 2024
High throughput screening identifies repurposable drugs for modulation of innate and acquired immune responses
Saeedeh Ghorbanalipoor, Kazuko Matsumoto, Natalie Gross, et al.
The Journal of Allergy and Clinical Immunology
|
December 15, 2015
IL-10 mediates plasmacytosis-associated immunodeficiency by inhibiting complement-mediated neutrophil migration
Upasana Kulkarni, Christian M Karsten, Thomas Kohler, et al.
Frontiers in Immunology
|
August 18, 2018
The p.Arg435His Variation of IgG3 With High Affinity to FcRn Is Associated With Susceptibility for Pemphigus Vulgaris-Analysis of Four Different Ethnic Cohorts
Andreas Recke, Sarah Konitzer, Susanne Lemcke, et al.
Frontiers in Medicine
|
June 27, 2022
Unmet Medical Needs in Chronic, Non-communicable Inflammatory Skin Diseases
Hideyuki Ujiie, David Rosmarin, Michael P Schön, et al.
Clinical and Experimental Rheumatology
|
May 8, 2026
Correction to: IL-1 targeting agents in Schnitzler syndrome: a multicentre, real-world study from the international AIDA Network Schnitzler Registry
Laura Calabrese, Alessandra Cartocci, Antonio Vitale, et al.
Clinical and Experimental Rheumatology
|
October 24, 2025
IL-1 targeting agents in Schnitzler syndrome: a multicentre, real-world study from the international AIDA Network Schnitzler Registry
Laura Calabrese, Alessandra Cartocci, Antonio Vitale, et al.
Frontiers in Medicine
|
August 4, 2022
Development and implementation of the AIDA international registry for patients with Schnitzler's syndrome
Jurgen Sota, Antonio Vitale, Ewa Więsik-Szewczyk, et al.
Frontiers in Medicine
|
January 28, 2026
Clinical and laboratory markers to distinguish VEXAS from Schnitzler's syndrome: data from the AIDA network registries
Valeria Caggiano, Jessica Sbalchiero, Micol Frassi, et al.
Page
of 9
Search research articles
Search
Showing results (71-80 of 83) with videos related to
Sort By:
Page
of 9
Journal of Autoimmunity
|
June 3, 2015
Allelic and copy-number variations of FcγRs affect granulocyte function and susceptibility for autoimmune blistering diseases
Andreas Recke, Gestur Vidarsson, Ralf J Ludwig, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology
|
August 6, 2025
Lanadelumab's impact on hereditary angioedema control and quality of life across disease activity subgroups: Real-world evidence
Andrea Zanichelli, Walter A Wuillemin, Emel Aygören-Pürsün, et al.
Journal of Autoimmunity
|
August 20, 2024
High throughput screening identifies repurposable drugs for modulation of innate and acquired immune responses
Saeedeh Ghorbanalipoor, Kazuko Matsumoto, Natalie Gross, et al.
The Journal of Allergy and Clinical Immunology
|
December 15, 2015
IL-10 mediates plasmacytosis-associated immunodeficiency by inhibiting complement-mediated neutrophil migration
Upasana Kulkarni, Christian M Karsten, Thomas Kohler, et al.
Frontiers in Immunology
|
August 18, 2018
The p.Arg435His Variation of IgG3 With High Affinity to FcRn Is Associated With Susceptibility for Pemphigus Vulgaris-Analysis of Four Different Ethnic Cohorts
Andreas Recke, Sarah Konitzer, Susanne Lemcke, et al.
Frontiers in Medicine
|
June 27, 2022
Unmet Medical Needs in Chronic, Non-communicable Inflammatory Skin Diseases
Hideyuki Ujiie, David Rosmarin, Michael P Schön, et al.
Clinical and Experimental Rheumatology
|
May 8, 2026
Correction to: IL-1 targeting agents in Schnitzler syndrome: a multicentre, real-world study from the international AIDA Network Schnitzler Registry
Laura Calabrese, Alessandra Cartocci, Antonio Vitale, et al.
Clinical and Experimental Rheumatology
|
October 24, 2025
IL-1 targeting agents in Schnitzler syndrome: a multicentre, real-world study from the international AIDA Network Schnitzler Registry
Laura Calabrese, Alessandra Cartocci, Antonio Vitale, et al.
Frontiers in Medicine
|
August 4, 2022
Development and implementation of the AIDA international registry for patients with Schnitzler's syndrome
Jurgen Sota, Antonio Vitale, Ewa Więsik-Szewczyk, et al.
Frontiers in Medicine
|
January 28, 2026
Clinical and laboratory markers to distinguish VEXAS from Schnitzler's syndrome: data from the AIDA network registries
Valeria Caggiano, Jessica Sbalchiero, Micol Frassi, et al.
Page
of 9